31.5.2021 12:40:11 CEST | Aqua Bio Technology ASA | Total number of voting rights and capital
Reference is made to the stock exchange announcement of Aqua Bio Technology (“ABT” or the “Company”) on 29 April 2021 regarding board approval of new shares in a completed private placement raising gross proceeds of approximately NOK 15 million (the “Private Placement”). The Private Placement was directed towards Akvakulturpartner AS, an investment company which focuses on attractive and innovate aquaculture opportunities, and certain other external investors.
The share capital increase pertaining to the issuance of the new shares towards Akvakulturpartner AS has today been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). ABT’s new share capital is NOK 49,257,695 divided into 19,703,078 shares, each with a nominal value of NOK 2.50.
The new shares issued in the Private Placement will initially be issued on a separate ISIN, and will only be converted to the ordinary ISIN of the Company’s shares following approval and publication of a listing prospectus.
For further information, please contact Espen Kvale, CEO, telephone +47 9162 8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT’s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the Company’s strategy going forward. ABT is listed on the Euronext Expand market of the Oslo Stock Exchange.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on Euronext Expand.
